Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 25;11(23):6944.
doi: 10.3390/jcm11236944.

Transcatheter Left Atrial Appendage Occlusion: A Multi-Center Real Life Experience

Ziad Arow  1   2 , Tzipi Hornik-Lurie  3 , Mustafa Gabarin  1   2 , Alexander Omelchenko  1   2 , Rami Barashi  1   2 , Yoav Arnson  1   2 , Abid Assali  1   2 , David Pereg  1   2
Affiliations

Transcatheter Left Atrial Appendage Occlusion: A Multi-Center Real Life Experience

Ziad Arow et al. J Clin Med. .

Abstract

(1) Background: left atrial appendage occlusion (LAAO) is considered an effective and relatively safe treatment for the prevention of thromboembolic events in patients with atrial fibrillation and a contra-indication for anticoagulation. We present a large multicenter real-world experience of transcatheter LAAO implementation in patients with atrial fibrillation who cannot be treated with chronic anti-coagulation; (2) Methods: included were atrial fibrillation patients who underwent transcatheter LAAO between 1 January 2016 and 30 June 2021. The study was conducted using the electronic health record database of Clalit Health Services (CHS). The primary outcomes included hemorrhagic and ischemic stroke following LAAO; (3) Results: included were 389 atrial fibrillation patients. During a median follow-up of 2.1 years, 13% patients had ischemic cerebrovascular accident (CVA), and 4.4% patients had hemorrhagic CVA. While the risk of ischemic stroke increased gradually over time, the risk of hemorrhagic CVA was highest during the first 3 months following the procedure. Moreover, previous ischemic stroke was the only significant predictor for both hemorrhagic and ischemic stroke following LAAO; (4) Conclusions: while the annual performance rate of transcatheter LAAO has increased significantly over the past years, post procedural long-term prognosis remains poor with a substantial risk of both thrombotic and bleeding events.

Keywords: anticoagulation; atrial fibrillation; hemorrhagic CVA; ischemic CVA; left atrial appendage occlusion.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(a) Risk of ischemic CVA following LAAO; (b) Risk of hemorrhagic CVA following LAAO.
See this image and copyright information in PMC

References

    1. Hindricks G., Potpara T., Dagres N., Arbelo E., Bax J.J., Blomström-Lundqvist C., Boriani G., Castella M., Dan G.A., Dilaveris P.E., et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 2021;42:373–498. - PubMed
    1. Osmancik P., Herman D., Neuzil P., Hala P., Taborsky M., Kala P., Poloczek M., Stasek J., Haman L., Branny M., et al. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients with Atrial Fibrillation. J. Am. Coll. Cardiol. 2020;75:3122–3135. doi: 10.1016/j.jacc.2020.04.067. - DOI - PubMed
    1. Boersma L.V., Ince H., Kische S., Pokushalov E., Schmitz T., Schmidt B., Gori T., Meincke F., Protopopov A.V., Betts T., et al. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year followup outcome data of the EWOLUTION trial. Heart Rhythm. 2017;14:1302–1308. doi: 10.1016/j.hrthm.2017.05.038. - DOI - PubMed
    1. Holmes D.R., Jr., Kar S., Price M.J., Whisenant B., Sievert H., Doshi S.K., Huber K., Reddy V.Y. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. J. Am. Coll. Cardiol. 2014;64:1–12. doi: 10.1016/j.jacc.2014.04.029. - DOI - PubMed
    1. Reddy V.Y., Sievert H., Halperin J., Doshi S.K., Buchbinder M., Neuzil P., Huber K., Whisenant B., Kar S., Swarup V., et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: A randomized clinical trial. JAMA. 2014;312:1988–1998. doi: 10.1001/jama.2014.15192. - DOI - PubMed

LinkOut - more resources